Agenus reported $92.85M in Current Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Amgen AMGN:US $ 24380M 5281M
AstraZeneca AZN:LN 26.69B 583M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Celldex Therapeutics CLDX:US $ 426.56M 258.95M
Chemocentryx CCXI:US $ 293.38M 23.75M
CSL CSL:AU $ 7.39B 753.5M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Genocea Biosciences GNCA:US $ 50.61M 12.3M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Glaxosmithkline GSK:US $ 18254M 688M
Immunogen IMGN:US $ 296.8M 22.41M
Intrexon XON:US $ 153.09M 3.59M
Jiangsu Hengrui Me. 600276:CH CH 30.36B 774.62M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Macrogenics MGNX:US $ 334.7M 32.3M
Merck MRK:GR € 10315M 133M
Northwest Biotherapeutics NWBO:US 6.31M 2.04M
Novartis NOVN:VX 26.25B 2.45B
Novavax NVAX:US $ 2174.18M 180.81M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Veracyte VCYT:US $ 229.31M 142.04M
YTE INCY:US $ 2923.8M 303.74M